| Filed On | Filing |
|---|---|
| 17 Dec 2024 |
Form 3: Ambrose Allison, General Counsel
No securities owned |
| 10 Oct 2024 | Form 3: Wellington Biomedical Innovation Master Investors (Cayman) Ii L.p., 10% owner |
| 10 Oct 2024 | Form 3: Sutherland Everett Rand, Director |
| 10 Oct 2024 |
Form 3: Chimovits Erez, Director
Holds 251,760 shares of Common Stock |
| 10 Oct 2024 |
Form 3: Beckman Daniella, Director
No securities owned |
| 10 Oct 2024 | Form 3: Houghton Adam, Chief Business Officer |
| 10 Oct 2024 | Form 3: Ruddy Marcella K., Director |
| 10 Oct 2024 |
Form 3: Ratcliffe Liam, Director
No securities owned |
| 10 Oct 2024 | Form 3: Deykin Aaron, Chief Medical Officer |
| 10 Oct 2024 |
Form 3: Fleming Harold Edward, Director
No securities owned |
| 10 Oct 2024 |
Form 3: Orbimed Advisors Llc, Director and 3 others
Holds 251,760 shares of Common Stock |
| 10 Oct 2024 | Form 3: Renaud Ronald C Jr, Director |
| 10 Oct 2024 | Form 3: Gray Michael, CFO and COO |
| 10 Oct 2024 | Form 3: Ai Upstream Llc, 10% owner and 4 others |
Loading...